TrialBrain : a journal of neurology2015

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Per Svenningsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.